Metropolitan Life Insurance Company (MetLife)’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,952
Closed -$8.58K 2373
2022
Q4
$8.58K Sell
3,952
-143
-3% -$1.18K ﹤0.01% 2318
2022
Q3
$49.1K Hold
4,095
﹤0.01% 1468
2022
Q2
$34.3K Hold
4,095
﹤0.01% 1733
2022
Q1
$35.5K Sell
4,095
-12,701
-76% -$122K ﹤0.01% 1784
2021
Q4
$190K Buy
16,796
+825
+5% +$9.8K ﹤0.01% 2065
2021
Q3
$201K Buy
15,971
+7,306
+84% +$67.3K ﹤0.01% 2066
2021
Q2
$70.4K Sell
8,665
-6,739
-44% -$58.4K ﹤0.01% 2643
2021
Q1
$142K Sell
15,404
-1,590
-9% -$16K ﹤0.01% 2239
2020
Q4
$164K Hold
16,994
﹤0.01% 2068
2020
Q3
$211K Buy
16,994
+2,516
+17% +$33.4K ﹤0.01% 1735
2020
Q2
$188K Buy
14,478
+604
+4% +$7.6K ﹤0.01% 1842
2020
Q1
$141K Buy
13,874
+570
+4% +$7.44K ﹤0.01% 1808
2019
Q4
$208K Sell
13,304
-956
-7% -$19.3K ﹤0.01% 1901
2019
Q3
$239K Buy
14,260
+12,684
+805% +$252K ﹤0.01% 1757
2019
Q2
$35K Buy
+1,576
New +$30.2K ﹤0.01% 2535

Other funds holding GOSS

Metropolitan Life Insurance Company (MetLife)'s GOSS Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 3,952 shares — an estimated $8.58K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in GOSS in Q2 2019 and held it in 15 quarters. The position peaked at $239K in Q3 2019. 111 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,952 Gossamer Bio shares in Q1 2023, an estimated $8.58K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Gossamer Bio in Q2 2019 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Gossamer Bio position peaked at $239K in Q3 2019.
  • 111 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.